The National Health Insurance Authority (NHIA) will from July this year rollout free treatment for children with sickle cell and cancer registered with the scheme. NHIA has adopted Hydroxyurea, a drug commonly used medicine for patients with SCD in developed countries approved by Ghana’s Food and Drugs Authority in 2018 …
Read More »National NHIS To Cover Hydroxyurea Sickle Cell Therapy – Bawumia Announces
Vice President, Dr Mahamudu Bawumia, has announced the Akufo-Addo government decision to absorb the cost of hydroxyurea, a modifying therapy for sickle cell patients under the National Health Insurance Scheme (NHIS). Hydroxyurea is a treatment process for sickle cell anaemia, which helps to prevent the formation of sickle-shaped red blood …
Read More »